Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.

Bruckner, H W

Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report. [electronic resource] - Cancer treatment reports Sep 1982 - 1713-7 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.

0361-5960


Adenocarcinoma--drug therapy
Antineoplastic Agents--therapeutic use
Female
Gastrointestinal Neoplasms--drug therapy
Humans
Male
Methotrexate--therapeutic use
Middle Aged
Myeloproliferative Disorders--chemically induced
Prognosis
Random Allocation
Razoxane--therapeutic use
Triazines--adverse effects